Curtin School of Population Health, Faculty of Health Science, Curtin University, Perth, Western Australia, Australia.
Department of Nutrition and Dietetics, Fiona Stanley Hospital, Perth, Western Australia, Australia.
Muscle Nerve. 2024 Nov;70(5):1010-1017. doi: 10.1002/mus.28245. Epub 2024 Sep 6.
INTRODUCTION/AIMS: Motor neuron disease (MND) is a progressive neurodegenerative condition with a limited life expectancy. There is very little data on mortality and its associated factors beyond 30 days following gastrostomy. We explored the demographic, clinical, and nutritional predictors for early mortality at 30, 90, and 180 days following gastrostomy in these patients.
This was a retrospective study involving 94 MND patients in Western Australia who underwent gastrostomy between 2015 and 2021. Patients were divided into two groups based on mortality at 30, 90, and 180 days post-gastrostomy. T-test (or Mann-Whitney), chi-square test and Fisher's exact test were used for detecting between-group differences in various factors. Multivariable logistic regression was used to identify factors associated with post-gastrostomy mortality at 90 and 180 days.
No mortality was attributable to gastrostomy-related complications. Lower forced vital capacity (FVC) (p = .039) and greater weight loss (%) (p = .022) from diagnosis to gastrostomy were observed in those who died within 30 days post-gastrostomy. Older age (p = .022), male sex (p = .041), lower FVC (p = .04), requiring but not tolerating noninvasive ventilation (p = .035), and greater weight loss (%) (p = .012) were independent predictors of 90-day post-gastrostomy mortality. However, only older age (p = .01) and greater weight loss (p = .009) were predictors of mortality at 180 days post-gastrostomy.
Our data indicated that mortality at 90 and 180 days was influenced by the weight loss (%) from diagnosis to gastrostomy, highlighting the importance of nutritional care in the MND population. Gastrostomy placement prior to substantial weight loss may reduce the risk of weight loss-associated mortality and warrants further investigation.
介绍/目的:运动神经元病(MND)是一种进行性神经退行性疾病,预期寿命有限。在胃造口术后 30 天之后,关于死亡率及其相关因素的数据非常有限。我们探讨了这些患者在胃造口术后 30、90 和 180 天内死亡率的人口统计学、临床和营养预测因素。
这是一项回顾性研究,涉及 2015 年至 2021 年间在西澳大利亚接受胃造口术的 94 名 MND 患者。根据胃造口术后 30、90 和 180 天的死亡率,将患者分为两组。T 检验(或曼-惠特尼检验)、卡方检验和 Fisher 精确检验用于检测两组间各种因素的差异。多变量逻辑回归用于确定与胃造口术后 90 天和 180 天死亡率相关的因素。
没有与胃造口术相关的并发症导致死亡。在胃造口术后 30 天内死亡的患者,从诊断到胃造口术的用力肺活量(FVC)(p=.039)和体重减轻百分比(%)(p=.022)较低。年龄较大(p=.022)、男性(p=.041)、较低的 FVC(p=.04)、需要但不能耐受无创通气(p=.035)和体重减轻百分比(%)(p=.012)是胃造口术后 90 天死亡率的独立预测因素。然而,只有年龄较大(p=.01)和体重减轻百分比较大(p=.009)是胃造口术后 180 天死亡率的预测因素。
我们的数据表明,90 天和 180 天的死亡率受到从诊断到胃造口术的体重减轻百分比的影响,突出了营养护理在 MND 人群中的重要性。在体重显著减轻之前进行胃造口术可能会降低与体重减轻相关的死亡率风险,值得进一步研究。